The deadline for claiming CME for this event was June 30, 2023.
Please contact firstname.lastname@example.org if you require assistance.
The Society for Cardiovascular Angiography and Interventions is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Society for Cardiovascular Angiography and Interventions designates this live activity for a maximum of 18.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 18.25 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
ABP Maintenance of Certification
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 18.25 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is SCAI’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
Nurses and Radiologic Technicians
This education activity has been approved for 18 nursing contact hours by the Cardiovascular & Pulmonary Continuing Education (CaPCE), who is accredited by the California Board of Registered Nursing, Provider Number CEP15311.
This activity has been approved for 18 AART Category A+ CE Credit and 3.5 AART Category A CE Credit by the Association of Vascular and Interventional Radiographers.
Acknowledgment of Commercial Support
SCAI has received unrestricted educational grants from Boston Scientific, Cordis, Edwards Lifesciences, Medtronic, Merit Medical, ReCor Medical, Shockwave Medical, and Terumo Medical Corporation. No in-kind commercial support was received.
Individuals in control of content reported the following relevant financial relationships with ineligible companies during the content development process for this activity. All relevant financial relationships were mitigated before the start of the activity.
J. Dawn Abbott: Boston Scientific Corp, Consulting; Medtronic, Consulting; Philips, Advisory Board; and Recor, Consulting.
Zahid Amin: Abbott, Consulting and Edwards Lifesciences, Consulting.
Aimee K. Armstrong: Abbott, Consulting; Cook Advanced Therapies, Consulting; Edwards Lifesciences, Consulting, PI; Medtronic, Consulting; and Siemens, PI.
David T. Balzer: Abbott, Proctor; Edwards Lifesciences, PI, Proctor; and Medtronic, PI, Proctor.
Wayne B. Batchelor: Abbott, Boston Scientific Corp., Medtronic, and Philips, Consulting.
Adnan K. Chhatriwalla: Abbott, Speaker. Boston Scientific Corp., PI; Edwards Lifesciences, Speaker; and Medtronic, Speaker.
Jay S. Giri: Boston Scientific Corp., Advisory Board, PI; inari medical, Advisory Board, PI.
Beau M. Hawkins: Behring and Hemostemix, PI.
Anbukarasi Maran: Abbott, Consulting, Speaker; Boston Scientific Corp., Consulting, Speaker; Cardiovascular Systems, Inc., Speaker; Medtronic, Speaker; and Philips, Speaker.
John C. Messenger: Philips, Principal Investigator.
Arnold H. Seto: Acist, Consulting, PI; Frond Medical, Advisory Board, Consulting, Ownership Interests; General Electric, Speaker; Janssen, Speaker; Medtronic, Consulting; Medicure, Consulting, Speaker; Terumo, Speaker.
Binita Shah: Philips, Advisory Board and Terumo Medical, Consulting.
Mirvat Alasnag, Joaquin E. Cigarroa, Andrew Michael Goldsweig, George S. Hanzel, Sohah Iqbal, Sasanka Jayasuriya, Kathleen Kearney, Duane S. Pinto, R. Kevin Rogers, and Ranya Sweis: No relevant financial relationships with commercial interests to disclose.
Sarah Badran, Joaquin E. Cigarroa, Andrew Michael Goldsweig, Sasanka Jayasuriya, and Duane S. Pinto: No relevant financial relationships with commercial interests to disclose.
Disclosures will be available in the conference app.
Disclosures will be published as they become available.
Robert Bartel and Rachel Pham: No relevant relationships with ineligible companies.
SCAI’s Independent Content
As a provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society’s policy to ensure balance, independence, objectivity, and scientific rigor in all its activities.
SCAI activities are developed by the SCAI Planners prior to and independent of commercial support. Members of the Annual Meeting Program Committee reviewed and approved this activity. If planners had relevant financial relationships, the agenda was peer reviewed by a member with no relevant financial relationships.
Mitigation of Relevant Financial Relationships
All participating planners, reviewers, faculty, and staff are required to disclose to SCAI all financial relationships with ineligible companies. SCAI identifies relevant financial relationships and mitigates them before the activity begins.
Content Validation Statement
SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations. All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection and analysis.
SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients.
SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company.
SCAI's educational content is free of marketing or sales of products or services. Faculty will not actively promote or sell products or services that serve their professional or financial interests during accredited education.
SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration (FDA), at first mention and where appropriate in the content.
How to Get Credit
SCAI will email the evaluation to confirmed attendees after the conference. To be counted as a confirmed attendee, please pick up your badge at the registration desk. Certificates will be sent immediately upon completion of the evaluation.